Intermittent Preventive Treatment of Malaria in Children: A Qualitative Study of Community Perceptions and Recommendations in Burkina Faso and Mali
Catherine Pitt(Johns Hopkins University), Lesong Conteh(Imperial College London), Halimatou Diawara(Université des Sciences, des Techniques et des Technologies de Bamako), Daniel Chandramohan(London School of Hygiene & Tropical Medicine), Brian Greenwood(MRC Unit the Gambia), Habibou Kaboré(Centre National de Recherche et de Formation sur le Paludisme), Dimlawendé J. Ouédraogo(Centre National de Recherche et de Formation sur le Paludisme), Samba Diarra(University of Bamako), Abdoulaye Traoré(Centre National de Recherche et de Formation sur le Paludisme), Diadier Diallo(London School of Hygiene & Tropical Medicine), Kibsbila Kouéla(Centre National de Recherche et de Formation sur le Paludisme), Amadou T. Konaté(Centre National de Recherche et de Formation sur le Paludisme), Alassane Dicko(University of Bamako)
Cited by 26
Related Papers
Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial
|The Lancet|2001|528
Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine
|New England Journal of Medicine|2015|451
Association between an MHC Class II Allele and Clearance of Hepatitis B Virus in the Gambia
|New England Journal of Medicine|1995|439
Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial
|The Lancet|2024|345
Heterozygote advantage for HLA class-II type in hepatitis B virus infection
|Nature Genetics|1997|319